Pharmodynamics : Receptor Theory Flashcards

1
Q

How to calculate g/L of acetylcholine that has a molecular weight of 146 in 1M solution ?

A

MWt x Molarity = g/L

146 x 1 = 146g/L

  • molecular weight means molecular weight in GRAMS.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does binding of a ligand obey the law of mass action ?

A

L + R = RLIgand receptor complex

  • reversible reaction
  • as you add more ligand or more receptor the eq would shift to the right and more ligand -receptor complexes would be made.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define affinity

A

Measure of strength of interaction between a ligand and a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does an agonist work ?

A
  • an agonist binds to a receptor.
  • binding of the agonist depends on AFFINITY
  • an agonist-receptor complex is made
  • receptor activation is governed by intrinsic efficacy which results in the receptor being activated conformation.
  • to generate a biological response EFFICACY is required
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain how an antagonist works ?

A
  • antagonist binds to receptor
  • this requires AFFINITY
  • an antagonist blocks the binding of the agonist which prevents the receptor being activated.
  • they have NO intrinsic efficacy which explains why there is no response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How can we measure binding of a ligand to a receptor experimentally ?

A
  • often by binding of a radioactively labelled ligand to cells or membranes
  • incubate radioligand and receptors
  • we separate the ligands that are bound and free and then measure the ligands that are bound.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is kd?

A

The concentration of drug at which 50% of receptors are occupied.

  • gives a measure of affinity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The lower the kd the ….. greater/lower the affinity ?

A

Greater the affinity because the lower the kd the less concentration required to occupy all 50% of receptor sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How can we treat heroin or morphine overdose ?

A

Naloxone is used to treat overdose

  • it has a very high affinity ( thus lower kd) than heroin
  • high affinity antagonist of u-opioid receptors
  • and eventually outcompetes heroin in the body

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is fentanyl and why is it very difficult to treat overdose in it ?

A
  • fentanyl is an opioid that causes euphoria
  • it has an agonist which has an extremely high affinity towards opioid receptors
  • often medications like naloxone cannot outcompete fentanyl.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Log10 of number =

A

Power by which 10 has to be raised to get that number

Eg log10 ( 1000) = 3 because 10^3 = 1000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does a response require in order to happen ?

A

EFFICACY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define EC50

A

Effective concentration giving 50% maximal response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is intrinsic efficacy ?

A

Ability to activate receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Define potency

A

Effective concentration that gives 50% of the maximal response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does potency depend on ?

A
  • BOTH AFFINITY
  • intrinsic efficacy
  • PLUS cell/tissue components eg number of receptors
17
Q

Define concentration and dose

A

Concentration - known concentration of drug at site of action

  • dose : concentration at site of action generally unknown eg dose to a patient in mg or mg/kg
18
Q

Why when treating asthma we need a highly selective drug ?

A

-drugs that act as agonists tend to target b2-adrenoreceptors in the airways , however because b-adrenoreceptors are elsewhere in the body eg b1-adrneoreceptors are found in the heart , non-selective drugs may increase force and rate of contraction!

19
Q

How does Salbutamol achieve selective specificity ?

A

Kd for b2- 1micromoles
Kd for b1- 20micromoles

  • this shows that there is only a 20 fold difference between the affinity towards beta1 and beta2 adrenoreceptors. Which suggests that selectivity is not that great. HOWEVER…
  • when salbutamol binds to beta2- adrenoreceptors, the receptors are activated very well compared to beta1-adrenoreceptors which suggests that salbutamol is enhanced by b2-selective efficacy.
20
Q

How does salmeterol achieve selective specificities

A
  • long acting drug
  • kd b1- 1900nm
  • kd b2- 0.5nm

= there is a 3455 fold difference in affinity which suggests that salmeterol selectivity is based on affinity , not selective efficacy

21
Q

What are the problems with salbutamol in people who have cardiovascular disease ?

A

the b1-adrenoreceptors are also activated resulting in heart rate increasing.

  • this could lead to problems such as angina
  • hypertension
22
Q

Give an example of one cell/tissue dependant factors that influence agonist potency ?

A

Number of receptors

23
Q

How does an increase in the number of receptors increase agonist potency ?

A
  • because we often have spare receptors left over
  • for example : if there were no spare receptors ( there were 10,000 receptors in a cell ) , a full response requires 100% occupnacy . This would mean it requires&raquo_space;»> kd concentration of drug. Eg if kd of drug is 1nm it would need 10-100 Nm of drug instead.
  • HOWEVER, with spare receptors ( if we have 20,000) . Only 50% occupancy required for full response (10,000). So it requires kd of drug. Eg if kd=1nm, it requires 1nm.
24
Q

Does changing receptors number affect maximal response ?

A

Yes it can

-

25
Q

How does receptors numbers vary in the body ?

A
  • they vary with cell type
  • they tend to increase with low activity in the cell , to up regulation
  • they tend to decrease with high activity to down regulation
26
Q

Define a partial agonist

A
  • a- binds to receptors , however has insufficient intrinsic efficacy for maximal response to be evoked. Thus , EMAX decreases.
27
Q

Give an example of a partial agonist that can be used to treat heroin addictions

A

Buprenorphine

28
Q

Outline how the partial agonist buorenorphine acts as an agonist but also an antagonist at the same time

A

1) buprenorphine has a higher affinity for the u-opioid receptors than heroin so would bind to the receptors preventing the binding of heroin thus acting as an antagonist
- at the same time it activates the receptors , but not enough to evoke a maximal response.

29
Q

Why can a heroin addict become very ill if they administered buprenorphine ?

A

Addict experiences withdrawal symptoms because buprenorphine is a partial agonist which means it would not evoke a maximal response at the opioid receptors which the body is not used to,

30
Q

What are the three types of antagonists?

A

1( reversible competitive antagonist

2) irreversible competitive antagonist
3) non competitive antagonist

31
Q

Define IC50

A

Concentration of antagonist giving 50% inhibition

32
Q

Reversible competitive antagonist

A

Competitive antagonists compete with agonist for binding

  • the inhibition is surmountable
  • causes a parallel shift to the right of the agonist - concentration response curve because more agonist concentration is required to outcompete the competitive antagonist
33
Q

Give an example of a reversible competitive antagonist

A
  • naloxone
  • high affinity for u-opioid receptors

-

34
Q

Irreversible competitive antagonists

A
  • with increased antagonist or increased time more receptors are blocked by antagonist
  • this is non-surmountable
  • this would cause a parallel shift to the right of the graph and at higher concentrations suppress the maximal response ( EMAX decreases)
35
Q

Define orthosteric site

A
  • the binding site where a ligand usually binds aka the active site
36
Q

Non competitive antagonist

A
  • binds to sllosteric site which results in a conformational change
  • this reduces orthosteric ligand affinity / and or efficacy
  • causes a parallel shift to the right - decreases maximal response at higher concentrations of non comp antagonist
37
Q

What is an example of a non competitive antagonist drug

A

Maraviroc